Humacyte Inc.

Humacyte Inc.

World Rank (Jan-05-2024)
16,215
Market Cap (Jan-05-2024)
0.278 Billion USD
World Rank (Jul-30-2023)
15,669
Market Cap (Jul-30-2023)
0.309 Billion USD
World Rank (Jan-07-2022)
11,893
Market Cap (Jan-07-2022)
0.644 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
HUMA
Market Cap (Mar-08-2026)
0.23
Headquarters City/State
North Carolina
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-26 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
286 Million USD
Total Liabilities in USD
164 Million USD
Total Equity in USD
122 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
HUMACYTE, INC.
Company Profile

Humacyte is a Clinical Stage Biotechnology Platform company developing universally implantable bioengineered human tissue at a commercial scale with the goal of improving the lives of patients and transforming the practice of medicine. The company total assets are 101 million USD as on 2020. The headquarters is in USA.

IPO Year
2020
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share